BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22158332)

  • 1. How informative is a negative finding in a small pharmacogenetic study?
    Bacanu SA; Whittaker JC; Nelson MR
    Pharmacogenomics J; 2012 Apr; 12(2):93-5. PubMed ID: 22158332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics: from bench to byte.
    Swen JJ; Wilting I; de Goede AL; Grandia L; Mulder H; Touw DJ; de Boer A; Conemans JM; Egberts TC; Klungel OH; Koopmans R; van der Weide J; Wilffert B; Guchelaar HJ; Deneer VH
    Clin Pharmacol Ther; 2008 May; 83(5):781-7. PubMed ID: 18253145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic mapping of pharmacogenetic regulatory variation.
    Raby BA
    Curr Pharm Des; 2009; 15(32):3773-81. PubMed ID: 19925428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics: from discovery to patient care.
    Shin J; Kayser SR; Langaee TY
    Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics in biological perspective.
    Kalow W
    Pharmacol Rev; 1997 Dec; 49(4):369-79. PubMed ID: 9443163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics and population pharmacokinetics: impact of the design on three tests using the SAEM algorithm.
    Bertrand J; Comets E; Laffont CM; Chenel M; Mentré F
    J Pharmacokinet Pharmacodyn; 2009 Aug; 36(4):317-39. PubMed ID: 19562469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings.
    Chang WC; Tanoshima R; Ross CJD; Carleton BC
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():65-84. PubMed ID: 33006916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline.
    Chaplin M; Kirkham JJ; Dwan K; Sloan DJ; Davies G; Jorgensen AL
    PLoS Med; 2020 Sep; 17(9):e1003344. PubMed ID: 32956352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [State of the art of pharmacogenetic diagnostics in drug therapy].
    Kirchheiner J; Seeringer A; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):995-1003. PubMed ID: 17013776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can pharmacogenetics help rescue drugs withdrawn from the market?
    Shah RR
    Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating heritability in pharmacogenetic studies.
    Marshall SL; Guennel T; Kohler J; Man M; Fossceco S
    Pharmacogenomics; 2013 Mar; 14(4):369-77. PubMed ID: 23438884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Pharmacogenetic Information in Food and Drug Administration Drug Labeling and the Table of Pharmacogenetic Associations.
    Cheng CM; So TW; Bubp JL
    Ann Pharmacother; 2021 Oct; 55(10):1185-1194. PubMed ID: 33384014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of a placebo/nocebo effect in pharmacogenetics.
    Haga SB; Warner LR; O'Daniel J
    Public Health Genomics; 2009; 12(3):158-62. PubMed ID: 19204418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of the G protein-coupled receptors.
    Thompson MD; Cole DE; Capra V; Siminovitch KA; Rovati GE; Burnham WM; Rana BK
    Methods Mol Biol; 2014; 1175():189-242. PubMed ID: 25150871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetic considerations in the elderly patient.
    Bright DR; Calinski DM; Kisor DF
    Consult Pharm; 2015 Apr; 30(4):228-39. PubMed ID: 25893701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and regulatory considerations in pharmacogenetic testing.
    Schuck RN; Marek E; Rogers H; Pacanowski M
    Am J Health Syst Pharm; 2016 Dec; 73(23):1999-2006. PubMed ID: 27864207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
    Lee YM; Manzoor BS; Cavallari LH; Nutescu EA
    Pharmacotherapy; 2018 Feb; 38(2):205-216. PubMed ID: 29286540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studies.
    Holmes MV; Shah T; Vickery C; Smeeth L; Hingorani AD; Casas JP
    PLoS One; 2009 Dec; 4(12):e7960. PubMed ID: 19956635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From bench to bedside: a diagnostics framework for pharmacogenetics research.
    Katz DA
    Mol Genet Metab; 2002; 77(1-2):57-60. PubMed ID: 12359130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics: potential role in the treatment of diabetes and obesity.
    Vella A; Camilleri M
    Expert Opin Pharmacother; 2008 May; 9(7):1109-19. PubMed ID: 18422469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.